BIOMARIN PHARMACEUTICAL INC Interest Payable, Current
BIOMARIN PHARMACEUTICAL INC (BMRN) had Interest Payable, Current of $47.13 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:InterestPayableCurrent · last filed 2026-08-06
- 2026-06-30: Interest Payable, Current $47.13M.
- 2026-03-31: Interest Payable, Current $9.46M.
- 2025-12-31: Interest Payable, Current $907.00K.
- 2013-03-31: Interest Payable, Current $921.00K.
| Period end | Interest Payable, Current |
|---|---|
| 2026-06-30 | $47.13M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $9.46M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $907.00K 10-Q · filed 2026-08-06 |
| 2013-03-31 | $921.00K 10-Q · filed 2013-04-29 |
| 2012-12-31 | $1.31M 10-Q · filed 2013-04-29 |
| 2012-09-30 | $2.68M 10-Q · filed 2012-10-29 |
| 2012-06-30 | $1.30M 10-Q · filed 2012-08-02 |
| 2012-03-31 | $2.68M 10-Q · filed 2012-04-30 |
| 2011-12-31 | $1.30M 10-K · filed 2013-02-26 |
| 2011-09-30 | $2.86M 10-Q · filed 2011-10-31 |
| 2011-06-30 | $1.65M 10-Q · filed 2011-08-01 |
| 2010-12-31 | $1.80M 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |